Vote Scores

Home / Companies / Axsome Therapeutics, Inc. / 5 Jun 2026

Meeting · year to 30 June 2026564 filers reporting

Axsome Therapeutics, Inc.: meeting of 5 Jun 2026

Votes reported on Form N-PX, item by item

564 Form N-PX filers reported votes at the Axsome Therapeutics, Inc. meeting of 5 Jun 2026. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

2 nominees; 54.0% of reported votes for; 106 filers withheld from or voted against at least one nominee.

704 vote records from 190 filers. 83 of the 190 filers that marked the item either way voted against management.

50.0% for0.0% against50.0% other43.7% against management190 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

801 vote records from 561 filers. 31 of the 538 filers that marked the item either way voted against management. 23 filers reported this item without a management mark.

89.8% for5.2% against5.0% other5.8% against management561 filers99.1% for0.9% against0.0% other0.9% against management40,017,467 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

352 vote records from 190 filers. 1 of the 190 filers that marked the item either way voted against management.

99.5% for0.0% against0.5% other0.5% against management190 filers100.0% for0.0% against0.0% other0.0% against management16,313,885 reported shares

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalNo reportForNo report
State Street and SPDRForForFor
American CenturyAbstain or withhold *Against *For
Franklin TempletonForForFor
InvescoForForFor
EquitableForForFor
Charles SchwabForForFor
Nuveen and TIAAAbstain or withhold *ForFor
ProShares and ProFundsAbstain or withhold *ForFor
John Hancock and ManulifeAbstain or withhold *ForFor
Morgan Stanley, Eaton Vance and CalvertAbstain or withhold *ForFor
J.P. MorganForForFor
Goldman SachsForForFor
PGIM and PrudentialAbstain or withhold *ForFor
Jackson National fundsForForFor
Northern Trust and FlexSharesForForFor
SEISplit or no voteForFor
T. Rowe PriceAbstain or withhold *ForFor
Lincoln FinancialAbstain or withholdForFor
VoyaAbstain or withhold *ForFor
First TrustAbstain or withhold *ForFor
Russell InvestmentsSplit or no voteForFor
NationwideForForFor
Victory CapitalAbstain or withhold *ForFor
Brighthouse FundsForForFor
Guggenheim and RydexAbstain or withhold *ForFor
Columbia ThreadneedleSplit or no voteForFor
BNY MellonAbstain or withhold *ForFor
PrincipalAbstain or withhold *ForFor
Pacific Life fundsForForFor
Global XSplit or no voteForFor
TransamericaAbstain or withhold *ForFor
Federated HermesForForFor
AllianceBernsteinNo reportForNo report
Hartford FundsForForFor
DWSAbstain or withhold *ForFor
AllspringAbstain or withhold *ForFor
MassMutualForForFor
VanEckSplit or no voteForFor
Macquarie and Delaware FundsAbstain or withhold *ForFor
Janus HendersonAbstain or withhold *ForFor
Neuberger BermanForForFor
Natixis and Loomis SaylesAbstain or withhold *ForFor
Lord AbbettNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Axsome Therapeutics, Inc. meeting?

564 Form N-PX filers reported votes at the meeting of 5 Jun 2026. On say-on-pay, 31 of 538 voted against management (5.8%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Axsome Therapeutics, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Axsome Therapeutics, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Axsome Therapeutics, Inc. with a meeting date within three days of 5 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.